Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of EMLA cream and lidocaine spray with/without lavender aromatherapy for AVF cannulation pain in hemodialysis
IRCT20171212037847N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Mar 2024
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of lidocaine + prilocaine and lidocaine in chronic kidney disease (CKD) (4 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Pain intensity during AVF cannulation. Started Mar 2024; status: completed.
02
Drugs
lidocaine + prilocainelidocaine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20171212037847N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171212037847N2.